This post was originally published on this site
hi there i m testing this space for ads.
hi there i m testing this space for ads.
hi there i m testing this space for ads. hi there i m testing this space for ads. hi there i m testing this space for ads.
why not why not are are are why the ads are not working, damn this is insane. causing issues like never before.
Healthcare clinicians prescribe 15 times more anti-diabetes medications than they do anti-obesity drugs, missing an important opportunity to control both diseases, researchers reported.
Their article, “Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s,” was published in the September issue of Obesity, the scientific journal of The Obesity Society.
Obesity is a well-known risk factor for developing diabetes. However, although a vast proportion of people with type.
Six anti-obesity medications are now approved by the U.S. Food and Drug Administration (FDA) as treatment in combination with.
“Obesity is a serious disease that is not getting serious treatment,” Charles Billington, MD, FTOS, past president and spokesman for The Obesity Society, said in a press release.
“Given the close tie between obesity and type 2 diabetes, treating obesity should be an obvious first step for healthcare providers to prevent and treat diabetes. By treating obesity, we may be able to decrease the number of patients with type.
The post Test Post appeared first on Diabetes News Journal.
The post Test Post appeared first on BioNewsFeeds.